Applications of 1-Boc-2-Benzyl-Piperidin-4-One in Industrial Manufacturing

As an established primary producer, we supply 1-Boc-2-Benzyl-Piperidin-4-One strictly for advanced synthesis in the fine chemicals sector. Our distribution is focused on manufacturers operating in compliance-controlled industries, with traceable end uses founded on technical demand and global regulatory expectations. The following segments represent the principal real-world applications, defined by precise industrial requirements and documented downstream usage.

1. Pharmaceutical Intermediate for CNS-Active API Synthesis

Our material serves as a protected piperidine scaffold essential in multi-step active pharmaceutical ingredient (API) synthesis, particularly in the psychiatry and neurology portfolios. Chemists rely on its N-Boc protection for selectivity during key carbonyl transformations and hydrogenations, ensuring high-yield conversion to subsequent intermediates for centrally acting drugs.

Industry compliance standards

• Current Good Manufacturing Practice (cGMP) guidelines (ICH Q7, FDA 21 CFR Part 210/211, EU GMP Part II)
• Relevant regional pharmacopoeias (USP, EP, JP), depending on API registration
• Controlled substance precursor regulations (where applicable and registered)
• Comprehensive traceability and batch record-keeping for GMP intermediates

Typical usage ratio

• 0.25–0.55 molar equivalents in multi-step synthesis routes, adjusted based on target molecule complexity and desired protection/deprotection efficiency

Downstream process integration

• Incorporated after initial amination or condensation as a temporary protection step; deprotection follows hydrogenation or acylation, supporting purity and stereo-selectivity in late-stage intermediate preparation

Final product types

• Patent and generic CNS drug APIs (e.g., arylpiperidine-structured pharmaceuticals used in schizophrenia, ADHD, or Parkinson’s therapies)
• Pilot and clinical phase intermediates for neuroactive molecule development

2. Intermediate for Opioid Antagonist Bulk Synthesis

Bulk chemical manufacturers deploy this molecule as a backbone in the highly regulated synthesis of opioid antagonist drug substances. The Boc-protected structure allows precise C-2 and C-4 transformations, helping process chemists manage side reactions in scale-up and regulatory compliant manufacturing runs, particularly for naloxone- and naltrexone-related scaffolds.

Industry compliance standards

• FDA Drug Master File (DMF) submission and adherence to 21 CFR regulatory pathways
• WHO GMP certification for facilities engaging in narcotic precursor handling
• National Controlled Substances Act frameworks (e.g., US DEA, Chinese Precursor List)
• Periodical audit requirements for raw material traceability in opioid API supply chains

Typical usage ratio

• 0.4–0.7 equivalents relative to key alkylating or ring-closure agents; adjusted for yield optimization and impurity profile management in each synthetic campaign

Downstream process integration

• Used as a core intermediate prior to piperidine ring contractions and fine-tuned in hydrogenolysis or deprotection reactors before the final salt formation

Final product types

• Pharmaceutical-grade opioid antagonist APIs (e.g., naloxone hydrochloride, naltrexone)
• Registered intermediates for emergency antidote and addiction treatment drugs

3. Building Block for Research-Scale Bioactive Heterocycle Synthesis

In contract research and custom synthesis environments, scientists utilize this compound as a skeleton for developing novel heterocyclic compounds with pharmacological potential. The Boc and benzyl groups enhance regioselective transformations, permitting exploration of analog libraries under stringent laboratory controls.

Industry compliance standards

• ISO 9001 certified production and analytical documentation
• REACH Registration, Evaluation, Authorization and Restriction of Chemicals (if relevant for import to Europe)
• Institutional and governmental occupational safety protocols (e.g., OSHA, ECHA)
• Material transfer agreements for supply into regulated research workflows

Typical usage ratio

• 5–20 mmol per synthetic batch, with quantities varying by target structure design and combinatorial library requirements

Downstream process integration

• Acts as a starter nucleophile or electrophile in microwave-assisted or conventional bench-top organic synthesis prior to further derivatization, typically in bonded-flask or pilot parallel reactors

Final product types

• Research-stage heterocyclic scaffolds for bioprofiling
• Analogue sets for pharmaceutical candidate screening projects
• Reference standards for medicinal chemistry groups

4. Precursor for Custom Fine Chemical and Specialty Intermediate Production

Our downstream fine chemical partners employ this protected piperidone as a high-purity intermediate in scalable syntheses of custom specialty chemicals, predominantly for companies working with advanced organic synthons requiring strict functional group management through multi-step production cycles.

Industry compliance standards

• ISO 14001 for environmental management in chemical processing
• National chemical inventory and registration rules (TSCA, China IECSC, EU REACH where applicable)
• Internal QC and material specification standards for specialty fine chemicals
• Certificate of Analysis (CoA) and third-party purity certification protocols

Typical usage ratio

• 0.3–1.0 equivalents based on downstream reaction stoichiometry and preservation of protected functionalities through consecutive steps

Downstream process integration

• Introduced during core structure assembly in specialty chemical production, with staged deprotection or substitution to introduce or protect sensitive substituents prior to isolation and purification

Final product types

• Custom-tailored functionalized intermediates for pharma, agrochemical, or materials R&D pipelines
• Advanced building blocks sold as fine chemical catalog items
• Bespoke molecules for contract production and kilo lab implementation